» Articles » PMID: 15526815

Role of KL-6 in Evaluating the Disease Severity of Rheumatoid Lung Disease: Comparison with HRCT

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2004 Nov 6
PMID 15526815
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the role of KL-6 (Krebs von den Lungen-6) in evaluating the disease severity of pulmonary lesions in rheumatoid arthritis (RA) compared with high resolution computed tomography (HRCT) findings.

Methods: Fifty serum KL-6 levels and HRCT images were prospectively obtained from 47 RA patients. Eight HRCT findings were classified into five grades. Patients were also divided into two groups according to the KL-6 threshold level and HRCT findings were evaluated.

Results: There was a positive correlation between the serum KL-6 level and the total CT score (r = 0.83). Reticular opacity most closely related to the serum KL-6 levels (r = 0.84). In the high KL-6 group (n = 10), the average CTscore was markedly increased (64.6 points) and severe honeycombing expanded into the whole lung. One case revealed diffuse ground glass opacity. In 12 of 40 cases in the normal KL-6 group, CT scores mildly increased compared with the other cases (over 20 points). The predominant finding of these cases could be classified into four types: (1) narrow spread honeycombing; (2) subtle fibrosis; (3) airway diseases; and (4) dense consolidation.

Conclusion: KL-6 is a useful marker to detect severe RA lung disease. It is also useful to distinguish non-fibrosis from fibrosis predominant cases. However, it sometimes could not detect early stage RA lung disease.

Citing Articles

Correlation between CT-based phenotypes and serum biomarker in interstitial lung diseases.

Shin B, Oh Y, Kim J, Park S, Lee K, Lee H BMC Pulm Med. 2024; 24(1):523.

PMID: 39427156 PMC: 11490112. DOI: 10.1186/s12890-024-03344-8.


Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD): Update on Prevalence, Risk Factors, Pathogenesis, and Therapy.

Sullivan D, Ascherman D Curr Rheumatol Rep. 2024; 26(12):431-449.

PMID: 39320427 DOI: 10.1007/s11926-024-01155-8.


Association of Serum Krebs von den Lungen-6 (KL-6) Levels and Disease Severity in Patients Hospitalized with COVID-19.

Evlice O, Bektas M, Kar F, Marim F, Kaya I, Yorukoglu K Infect Dis Clin Microbiol. 2024; 5(4):292-299.

PMID: 38633849 PMC: 10986708. DOI: 10.36519/idcm.2023.260.


Association of Serum Biomarkers With Pulmonary Involvement of Rheumatoid Arthritis Interstitial Lung Disease: From KORAIL Cohort Baseline Data.

Moon J, Lee J, Yoon Y, Chang S, Lee Y, Ha Y J Rheum Dis. 2023; 28(4):234-241.

PMID: 37476358 PMC: 10324911. DOI: 10.4078/jrd.2021.28.4.234.


Understanding Interstitial Lung Diseases Associated with Connective Tissue Disease (CTD-ILD): Genetics, Cellular Pathophysiology, and Biologic Drivers.

Cerro Chiang G, Parimon T Int J Mol Sci. 2023; 24(3).

PMID: 36768729 PMC: 9917355. DOI: 10.3390/ijms24032405.